Mitsuaki Oki

Hirakata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A case of female dystrophinopathy with presumed childhood onset, presenting with asymmetric muscle weakness and delayed diagnosis in old age

A case of female dystrophinopathy with presumed childhood onset, presenting with asymmetric muscle weakness and delayed diagnosis in old age

Journal: Rinsho shinkeigaku = Clinical neurology

Published: July 08, 2026

Neurogenesis defects in iPSC-derived midbrain organoids of early-onset Parkinson's disease with 22q11.2 deletion syndrome.

Neurogenesis defects in iPSC-derived midbrain organoids of early-onset Parkinson's disease with 22q11.2 deletion syndrome.

Journal: Frontiers in cellular neuroscience

Published: June 11, 2026

Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With Tumor Recurrence During Atezolizumab Therapy.

Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With Tumor Recurrence During Atezolizumab Therapy.

Journal: Cureus

Published: December 14, 2025

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Journal: Clinical neuropharmacology

Published: December 02, 2025

Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Journal: Experimental neurology

Published: April 15, 2025

Lateral Medullary Infarction Presenting as Opalski Syndrome Associated with Headache Attributed to Orthostatic Hypotension.

Lateral Medullary Infarction Presenting as Opalski Syndrome Associated with Headache Attributed to Orthostatic Hypotension.

Journal: Internal medicine (Tokyo, Japan)

Published: April 13, 2025

Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.

Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.

Journal: Neuropharmacology

Published: May 13, 2021

GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.

GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.

Journal: Journal of neurology

Published: April 07, 2018

Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats.

Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats.

Journal: Neuroscience research

Published: February 01, 2017

Weight loss in the early stage of progressive supranuclear palsy.

Weight loss in the early stage of progressive supranuclear palsy.

Journal: Brain and behavior

Published: May 28, 2016

The role of p62/SQSTM1 in sporadic inclusion body myositis.

The role of p62/SQSTM1 in sporadic inclusion body myositis.

Journal: Neuromuscular disorders : NMD

Published: April 28, 2016

Early-onset Parkinson's Disease Associated with Chromosome 22q11.2 Deletion Syndrome.

Early-onset Parkinson's Disease Associated with Chromosome 22q11.2 Deletion Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: February 03, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026